Sachiyo Minegishi
No más puestos en curso
Historial de carrera de Sachiyo Minegishi
Antiguos cargos conocidos de Sachiyo Minegishi.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01/04/2016 | 01/09/2020 |
AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2012 | 01/04/2016 |
AKOUOS | Director Financiero/CFO | 01/10/2020 | - |
Formación de Sachiyo Minegishi.
Massachusetts Institute of Technology | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Sachiyo Minegishi
- Experiencia